After acquiring a 95% stake in Ho Chi Minh City-based Torex Vietnam Semiconductor, Taiwanese semiconductor manufacturer Panjit has approved an additional $45 million investment in its production facility in Vietnam.

The move reflects the company’s ambition to transform its HCMC plant into a key hub in the supply chain for power semiconductors, integrated circuits (ICs), automotive electronics, and green energy solutions.

In a recent filing with the Taiwan Stock Exchange, Panjit International Inc. said the investment will be implemented in phases following board approval and financed through internal funds and bank loans.

The investment aims to expand the company’s overseas manufacturing capacity, thereby improving flexibility and competitiveness in regional production allocation.

This marks the latest move by the Taiwanese semiconductor company in Vietnam, six months after its acquisition of a majority stake in Torex Vietnam Semiconductor, a subsidiary of Japan’s Torex Semiconductor Ltd.

In November 2025, Panjit announced that its board had approved the acquisition of a 95% stake in Torex Vietnam Semiconductor Co., Ltd. Following the transaction, Torex Semiconductor retained the remaining 5% stake in the company.

According to DigiTimes, Panjit allocated approximately $10 million in internal funds for the acquisition. The deal was aimed at expanding Panjit’s product portfolio by bringing automotive-grade power semiconductor packaging and testing lines to Vietnam, thereby strengthening the company’s position in the AI, automotive, power supply, and green energy sectors.

From acquiring Torex Vietnam to expanding manufacturing

Torex Vietnam Semiconductor was established in 2008 and is located in the VSIP II Industrial Park, formerly in Binh Duong province and now part of HCMC. The factory mainly specializes in semiconductor packaging and testing, including IC packaging and testing services.

The company uses USP (Ultra Small Package) technology, an ultra-miniature packaging technology designed to support the trend toward increasingly compact semiconductor components while maintaining high performance and reliability.

Before the transaction with Panjit, Torex Vietnam had charter capital of $5.8 million and total assets of $6.6 million as of the end of March 2025.

Panjit’s additional $45 million investment in the Vietnamese production facility is therefore significantly larger than Torex Vietnam’s previously disclosed asset base.

This suggests that the HCMC plant will not only continue operating as a packaging and testing facility but will also likely be upgraded to support Panjit’s broader product strategy.

In its November 2025 statement, Panjit said the investment in Torex Vietnam would strengthen the company’s manufacturing footprint in Southeast Asia, increase production flexibility, improve supply chain resilience, and enhance global competitiveness.

The company also emphasized that diversifying manufacturing locations has become increasingly important amid rising geopolitical uncertainties and the ongoing restructuring of global supply chains.

Bringing automotive-grade products to Vietnam

One notable aspect of Panjit’s strategy is the introduction of automotive-grade power semiconductor production at its Vietnam facility.

According to information released by Panjit one month after the signing ceremony with Torex, the company plans to expand automotive-grade manufacturing capacity at the Vietnam plant by installing new equipment and adding two new production lines.

These lines are designed to meet the requirements of Tier 1 automotive customers. Mass production is expected to begin in the third quarter of 2026.

This is a significant development because the automotive industry, particularly electric vehicles and in-vehicle electronic systems, is one of the fastest-growing markets for power semiconductors.

Products such as diodes, MOSFETs (metal-oxide-semiconductor field-effect transistors), SiC components, protection devices, and other power devices play a crucial role in power management, energy conversion, circuit protection, and energy control.

Panjit operates under the IDM (integrated device manufacturer) model, which integrates design, manufacturing, packaging, testing, and sales. Its product portfolio includes ICs, IGBTs (insulated-gate bipolar transistors), MOSFETs, diodes, SiC components, diode rectifiers, protection devices, transistors, and bridge rectifiers. Panjit’s customers span the automotive, power supply, industrial, computing, consumer electronics, and communications sectors.

Việt Nam spent approximately US$2.93 billion importing nearly 3.37 million tonnes of petroleum products in the first quarter of 2026, an increase of 77.8 per cent in value and over 44 per cent in volume compared to the same period last year.

HÀ NỘI — Việt Nam's energy imports have increased sharply in the first three months of 2026, reflecting a rapid recovery in domestic consumption demand along with pressure to secure supply in the face of geopolitical instability and global energy price fluctuations.

Data from Việt Nam Customs shows that the country spent approximately US$2.93 billion importing nearly 3.37 million tonnes of petroleum products in the first quarter of 2026, an increase of 77.8 per cent in value and over 44 per cent in volume compared to the same period last year.

Aside from refined petroleum products, many other energy products also recorded a sharp increase, including coal imports, which rose by 76.4 per cent to nearly $2.8 billion, and crude oil, which surged by 381 per cent to $2.4 billion.

In the first half of April, the upward trend in imports continued, with import value of crude oil and petroleum products approaching $1.25 billion.

Experts attributed the sharp increase in energy imports this year to the rebound of domestic consumption in the wake of a recovered industrial production. The steel, cement, chemical, thermal power and transportation sectors have all recorded higher fuel consumption compared to the same period last year.

Meanwhile, domestic energy supply has not met demand. Domestic crude oil production has been declining for many years due to major fields entering a natural depletion phase.

At the same time, the country's two main refineries, Dung Quất and Nghi Sơn, although operating, are still insufficient to fully meet market demand, especially during periods of significant global oil price fluctuations.

Another factor causing the surge in energy imports was the impact of global geopolitical instability. Conflict in the Middle East in the first quarter caused international oil prices to surge at times, leading to escalating energy import costs. According to the Ministry of Industry and Trade, key businesses have had to significantly increase imports since March to ensure domestic supply and maintain safe inventory levels.

Experts forecast that the trend of sharply increasing energy imports will continue for the next few years as the economy maintains its high growth target, while many gas-fired power, petrochemical and heavy industry projects are put into operation. This will put a significant pressure on trade balance as well as national energy security strategy.

VOV.VN - The Republic of Korea’s Samil Pharmaceutical is expanding its operations in Vietnam to reduce production costs and seek new growth opportunities.

The move comes as the company’s Chairman Heo Seung Beom increases his shareholding to support the company’s third-generation leadership transition.

Established in 1947, Samil Pharmaceutical is widely known in the Republic of Korea for its children’s antipyretic medicine Brupen. It also manufactures and markets pharmaceuticals and nutraceuticals including Libact, Foributin and Monoprost.

Under its strategic shift, the company is increasingly focusing on overseas production. In 2022, Samil Pharmaceutical completed a contract development and manufacturing organisation (CDMO) facility in Vietnam specialising in ophthalmic products.

The plant spans about 24,800 square metres and has an annual production capacity of 330 million eye-drop units.

The company aims to take advantage of lower labour costs in Vietnam to strengthen its price competitiveness. However, the facility has not yet entered full-scale commercial production, as it awaits Good Manufacturing Practice (GMP) approvals in key target markets.

Following GMP certification from Vietnamese authorities in 2024, Samil Pharmaceutical is now seeking approval from the RoK’s Ministry of Food and Drug Safety in the second half of this year. The company said the approval process is expected to take around two to three months.